The FDA just approved a new Alzheimer's drug that's set to be a blockbuster

Jan 6 2023 by Business Insider

 

Getty Images

The FDA just approved a new treatment for Alzheimer's disease from Eisai and Biogen.  In a large study, the drug slowed the rate of cognitive decline in patients by 27%. Alzheimer's disease affects roughly 6.5 million Americans and has no cure.

The US Food and Drug Administration approved a new drug for Alzheimer's disease — a key step forward in treating the disease.

Lecanemab, developed by the Cambridge-based biotech company Biogen and the Japanese pharmaceutical company...

Continue Reading The FDA just approved a new Alzheimer's drug that's set to be a blockbuster